Are you a healthcare professional?
Is this your profile?
background
background
Dr. Peter Sordillo, MD

Dr. Peter Sordillo, MD

Oncology*
50+ years of experience

Dr. Peter Sordillo, MD is an oncology specialist in New York, NY and has over 50 years of experience in the medical field. He graduated from NEW YORK Medical College in 1974. He is affiliated with Lenox Hill Hospital. He is accepting new patients.

5 Star Rating
Based on 1 review 5 Star Rating (1 review)

Peter Sordillo, M.D., PhD

51 E 82nd St # 1A1A New York, NY 10028

Make an Appointment

Experience Check

Search for experience in a specific area

Dr. Sordillo's Reviews

Likelihood to recommend Dr. Sordillo

5.0

1 rating
5 Star
100%
100%
4 Star
0%
0%
3 Star
0%
0%
2 Star
0%
0%
1 Star
0%
0%

Leave a review

How was your experience with Dr. Sordillo?

About Me

care philosophy

I believe that each person's life has infinite value, and that a physician's duty is solely to his patient. I also believe in giving each patient all the information regarding his cancer, whether good or bad.
  • Oncology

  • Breast Oncology

  • Medical Oncology

  • Thoracic Oncology

  • Gastrointestinal Oncology

  • Dermatologic Oncology

  • Radiation Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

  • New York University

    2007
  • New York University Ms Physics

    2001
  • Columbia University Phd Philosophy

    1990
  • Sloan Kettering Cancer Center

    Residency Hospital, 1981
  • Memorial Hospital For Cancer And Allied Diseases

    Fellowship Hospital, 1981
  • Lenox Hill Hospital

    Internship Hospital, 1975
  • New York Medical College

    Medical School, 1974
  • Columbia University Vagelos College Of Physicians And Surgeons

    Undergraduate School, 1970
  • Columbia University

    Undergraduate School, 1970
American Board of Medical Specialties®
American Board of Internal Medicine®
Internal Medicine
Medical Oncology
For detailed information about any of the below board actions, please search for the provider's records on the linked state licensing board or the Federation of State Medical Boards. To learn more about the difference between these sources, please refer to our FAQs.
Healthgrades has not received any data indicating a board action exists for this provider.
  • Paired-study comparison of N-13 L-Valine and L-glutamate in human sarcomas, 1986

  • Phase II trial of cisplatinum (CPDD) in previously treated patients with advanced soft tissue sarcoma, 1982

  • Adenosine diphosphante ribosyl transferase responses to a standarlized dose of hydrogen peroxide in the mononuclear leukocytes of patients with a diagnosis of cancer, 1989

  • Comparative uptake of positron emitting biomolecules in hepatoma heterotransplants: PET feasibility studies, 1988

  • Further characterization of a transplantable murine osteogenic sarcoma, 1986

  • Malignant mesothelioma of the pleura: Review of 123 patients, 1982

  • Extraosseous osteogenic sarcoma: Review of 48 patients, 1983

  • Effects of Phase I and II chemotherapeutic agents against human lymphomas heterotransplanted in nude mice, 1983

  • Seventeem year survival in a patient with metastatic malignant peritoneal mesothelioma, 1981

  • Chemotherapy of patients with advanced soft tissue sarcoma with use of DVA (vindesine sulfate), adriamycin and cyclophamide (DAC), 1983

  • Malignant peritoneal mesothelioma: Review of 25 cases, 1981

  • Lymphomatoid granulomatosis, 1982

  • Tumor detection and imaging in patients with malignant using carbon-11 labeled alpha-aminoisobutyric acid, 1991

  • The influence of antineoplastic chemotherapy on antipyrine metabolism, 1989

  • Primary hemangiosarcoma of the spleen, 1981

  • Malignant schwannoma, 1981

  • Search for evidence of feline leukemia virsus infection in humans with leukemias, lymphomas, or soft-tissue sarcomas, 1982

  • An unexpected induction of microsomal drug metabolism by antitumor antibiotics, 1986

  • Fetal tissue research and transplantation, 1993

  • Ethical and social issues in organ procurement for transplantation, 1993

  • HIV-associated Hodgkins disease: A clinicopathologic study of 18 cases, 1991

  • Lymphangiosarcoma, 1981

  • Combimation chemotherapy of advanced sarcomas in adults with "CYOMAD"(S7), 1982

  • Medical futility, 1992

  • Chemotherapy of metastatic sweat gland carcinoma, 1985

  • Scanning with N-13-L-glutamate, 1982

  • Imaging of human tumors and organs with N-13 labelled L-methionine, 1986

  • Quantitative scanning of soft-tissue sarcomas with nitrogen-13-labeled-L-glutamate, 1983

  • Chemotherapy for Unresectable Soft Tissue Sarcomas in Soft Tissue Sarcomas (John H. Raaf, ed.), 1993

  • Imaging studies using C-11 alpha-aminoisobutyric acid (AIB) in patients with malignant melanoma, 1988

  • Adjuvant chemotherapy of soft-part sarcomas with ALOMAD (S4), 1981

  • Fellow, American College of Physicians, current

  • American Cancer Society Junior Faculty Award, 1983-1984

  • Fellow, American Cancer Society, 1977-1978

  • American Cancer Society Junior Faculty Award, 1984-1985

  • American Cancer Society Junior Faculty Award, 1982-1983

  • National Research Service Award, N.C.I., 1978-1979

Insurance Check

Search for your insurance carrier and choose your plan type

Locations

Peter Sordillo, M.D., PhD

Office51 E 82nd St # 1A1A New York, NY 10028
1